Logo for Daré Bioscience Inc

Daré Bioscience Investor Relations Material

Latest events

Logo for Daré Bioscience Inc

Q3 2023

Daré Bioscience
Logo for Daré Bioscience

Corporate Presentation

12 Nov, 2023
Logo for Daré Bioscience

Q3 2023

9 Nov, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Daré Bioscience Inc

Access all reports
Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in the identifying, developing and marketing products for women's health. The firm focuses on women's reproductive health management which includes contraception and treatment of endometriosis and infertility. Daré Bioscience is developing VASCAZEN as a nonhormonal oral contraceptive that is intended to have no estrogen or progestin side effects such as weight gain and fluid retention as well as its potential effect by regulatory authorities to make it available more quickly than fully approved new drugs.